Félix López Cadenas

The transcription factor DDIT3 is a potential driver of dyserythropoiesis in myelodysplastic syndromes

Nerea Berastegui, Marina Ainciburu, Juan P. Romero et al. · Nature Communications · 2022 · 26 citations · Full text

Life Sciences, Genetics, Hematology +9

Co-occurrence of cohesin complex and Ras signaling mutations during progression from myelodysplastic syndromes to secondary acute myeloid leukemia

Marta Martín‐Izquierdo, María Abáigar, Jesús María Hernández-Sánchez et al. · Haematologica · 2020 · 21 citations · Full text

Medicine, Genetics, Hematology +17

Response to Treatment with an Anti-Interleukin-6 Receptor Antibody (Tocilizumab) in a Patient with Hemophagocytic Syndrome Secondary to Immune Checkpoint Inhibitors

Alejandro Olivares-Hernández, Luis Figuero-Pérez, María Antonieta Martin et al. · Case Reports in Oncological Medicine · 2021 · 20 citations · Full text

Medicine, Hematology, Oncology +17

Phase 1 Study of JNJ-64619178, a Protein Arginine Methyltransferase 5 Inhibitor, in Patients with Lower-Risk Myelodysplastic Syndromes

Tamanna Haque, Félix López Cadenas, Blanca Xicoy et al. · Blood · 2021 · 20 citations

Medicine, Pharmacology, Pharmacotherapy +6

Phase 1 study of JNJ-64619178, a protein arginine methyltransferase 5 inhibitor, in patients with lower-risk myelodysplastic syndromes

Tamanna Haque, Félix López Cadenas, Blanca Xicoy et al. · Leukemia Research · 2023 · 19 citations

Medicine, Pharmacology, Pharmacotherapy +6